17 April 2015 | News | By BioSpectrum Bureau
China approves Waters' UPLC I-Class system
These systems can be used by clinical laboratories to perform qualitative and quantitative analyses of patients' samples
Singapore: The Chinese food and drug administration has approved the usage of Waters' ACQUITY UPLC I- Class IVD/Xevo TQ-S IVD System for in-vitro diagnostic use in the country. Last year, the regulatory body had approved another product from the same line, ACQUITY TQD System for diagnostic use. These systems are used for clinical analysis of compunds used to monitor and for diagnosis.
Said Mr Jeff Mazzeo, senior director, Health Sciences for Waters Division, "The practice of medicine is changing from a reactive approach to treating disease, to one that is more proactive and preventive." He added further, "To facilitate this transition, better diagnostic and predictive tools are needed so that disease can be detected earlier or even prevented. That is where Waters technologies, approved for IV diagnostic use make an impact."
These systems can be used by clinical laboratories to perform qualitative and quantitative analyses of patients' samples and simplify the process for clinicians. They help confirm a suspicion or a diagnosis; assist in the selection and monitoring of a treatment; provide a prognosis; screen for a disease in the absence of clinical signs or symptoms; and establish and monitor the severity of physiological disturbance.